The Journal of Practical Medicine ›› 2023, Vol. 39 ›› Issue (5): 544-549.doi: 10.3969/j.issn.1006⁃5725.2023.05.004

• Special topic written talk • Previous Articles     Next Articles

Research progress in the pathology and treatment of large cell lung carcinoma

YANG Yang，ZHANG Zhiyuan， FU Weiping.   

  1. Department of Respiratory and Critical Care Medicine，the First Affiliated Hospital of Kunming Medical University，Kunming 650000，China 
  • Online:2023-03-10 Published:2023-03-10
  • Contact: FU Weiping E⁃mail：fuweiping2@163.com
  • Supported by:


Abstract:

Large cell lung carcinoma（LCLC）is an undifferentiated non⁃small cell lung cancer that lacks the morphological and immunological markers of adenocarcinoma，squamous cell carcinoma，and small cell carci⁃ noma. LCLC has a low incidence and poor prognosis. The incidence of LCLC is less than 1% of lung cancer surgical specimens. Systemic comprehensive treatment is the main treatment. This article reviews the research progress in the pathological diagnosis and treatment of LCLC in recent years，aiming to provide a reference for further research and treatment.

Key words:

large cell carcinoma, lung, diagnosis, treatment